Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Bernard Durand

Showing results (1-10 of 79) with videos related to

Pageof 8
Sort By:
Journal of Clinical Hypertension (Greenwich, Conn.)|April 10, 2004
Heart failure management in African Americans: meeting the challengeJean-Bernard Durand
Ethnicity & Disease|March 27, 2002
Current guidelines in heart failure managementJean-Bernard Durand
The American Journal of Medicine|December 28, 2005
Management of heart failure in the elderlySyed W Yusuf, Jean-Bernard Durand
Texas Heart Institute Journal|July 2, 2011
Cardiovascular interventions in thrombocytopenic cancer patientsCezar Iliescu, Jean-Bernard Durand, Michael Kroll
Expert Opinion on Drug Safety|April 9, 2013
Cardiovascular toxicity of tyrosine kinase inhibitorsElie Mouhayar, Jean-Bernard Durand, Jorge Cortes
The New England Journal of Medicine|June 17, 2011
Erlotinib or gefitinib for non-small-cell lung cancerSyed W Yusuf, Peter Kim, Jean-Bernard Durand
Current Opinion in Cardiology|April 21, 2004
The update on the rationale, use and selection of beta-blockers in heart failureGregory Giesler, Daniel J Lenihan, Jean-Bernard Durand
Mediterranean Journal of Hematology and Infectious Diseases|July 19, 2021
Ibrutinib-Associated Cardiovascular Events in a Patient Wearing an Implanted Loop RecorderDaniel Rivera, Koichi Takahashi, Jean-Bernard Durand, et al.
The American Journal of Medicine|May 1, 2007
Wrap beatsSyed Wamique Yusuf, Jean-Bernard Durand, Daniel J Lenihan
Blood|April 24, 2007
Congestive heart failure is a rare event in patients receiving imatinib therapyEhab Atallah, Jean-Bernard Durand, Hagop Kantarjian, et al.
Pageof 8

Showing results (1-10 of 79) with videos related to

Sort By:
Pageof 8
Journal of Clinical Hypertension (Greenwich, Conn.)|April 10, 2004
Heart failure management in African Americans: meeting the challengeJean-Bernard Durand
Ethnicity & Disease|March 27, 2002
Current guidelines in heart failure managementJean-Bernard Durand
The American Journal of Medicine|December 28, 2005
Management of heart failure in the elderlySyed W Yusuf, Jean-Bernard Durand
Texas Heart Institute Journal|July 2, 2011
Cardiovascular interventions in thrombocytopenic cancer patientsCezar Iliescu, Jean-Bernard Durand, Michael Kroll
Expert Opinion on Drug Safety|April 9, 2013
Cardiovascular toxicity of tyrosine kinase inhibitorsElie Mouhayar, Jean-Bernard Durand, Jorge Cortes
The New England Journal of Medicine|June 17, 2011
Erlotinib or gefitinib for non-small-cell lung cancerSyed W Yusuf, Peter Kim, Jean-Bernard Durand
Current Opinion in Cardiology|April 21, 2004
The update on the rationale, use and selection of beta-blockers in heart failureGregory Giesler, Daniel J Lenihan, Jean-Bernard Durand
Mediterranean Journal of Hematology and Infectious Diseases|July 19, 2021
Ibrutinib-Associated Cardiovascular Events in a Patient Wearing an Implanted Loop RecorderDaniel Rivera, Koichi Takahashi, Jean-Bernard Durand, et al.
The American Journal of Medicine|May 1, 2007
Wrap beatsSyed Wamique Yusuf, Jean-Bernard Durand, Daniel J Lenihan
Blood|April 24, 2007
Congestive heart failure is a rare event in patients receiving imatinib therapyEhab Atallah, Jean-Bernard Durand, Hagop Kantarjian, et al.
Pageof 8